Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
N05BA04
|
| gptkbp:brand |
gptkb:oxazepam
|
| gptkbp:contraindication |
gptkb:myasthenia_gravis
severe respiratory insufficiency sleep apnea syndrome hypersensitivity to benzodiazepines |
| gptkbp:discoveredBy |
gptkb:Schwarz_Pharma
|
| gptkbp:drugClass |
benzodiazepine
|
| gptkbp:eliminationHalfLife |
5-15 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Serax
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
1965
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
confusion
dizziness fatigue headache drowsiness |
| gptkbp:usedFor |
anxiety disorders
alcohol withdrawal |
| gptkbp:bfsParent |
gptkb:oxazepam
|
| gptkbp:bfsLayer |
7
|